Patents by Inventor Christian Rummey

Christian Rummey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
    Patent number: 8236818
    Abstract: The present invention relates to substituted imidazopyridine derivatives as melanocortin-4 receptor (MC-4R) modulators, in particular as melanocortin-4 receptor antagonists. The antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, amytrophic lateral sclerosis (ALS), anxiety and depression.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: August 7, 2012
    Assignee: Santhera Pharmaceuticals (Schweiz) AG
    Inventors: Günther Metz, Holger Deppe, Ulrich Abel, Achim Feurer, Inge Ott, Sonja Nordhoff, Michael Soeberdt, Barbara Hoffmann-Enger, Philipp Weyermann, Hervé Siendt, Christian Rummey, Miroslav Terinek, Marco Henneböhle, Holger Herzner, Cesare Mondadori
  • Substituted Heteroarylpiperidine Derivatives As Melanocortin-4 Receptor Modulators
    Publication number: 20100249093
    Abstract: The present invention relates to substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, amyotrophic lateral sclerosis (ALS), anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention.
    Type: Application
    Filed: July 18, 2008
    Publication date: September 30, 2010
    Applicant: SANTHERA PHARMACEUTICALS (SCHWEIZ) AG
    Inventors: Marco Henneböhle, Holger Herzner, Michael Soeberdt, Philipp Weyermann, Sonja Nordhoff, Achim Feurer, Holger Deppe, Hervé Siendt, Miroslav Terinek, Christian Rummey
  • Substituted Imidazopyridine Derivatives As Melanocortin-4 Receptor Antagonists
    Publication number: 20100093697
    Abstract: The present invention relates to substituted imidazopyridine derivatives as melanocortin-4 receptor (MC-4R) modulators, in particular as melanocortin-4 receptor antagonists. The antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, amytrophic lateral sclerosis (ALS), anxiety and depression.
    Type: Application
    Filed: March 28, 2008
    Publication date: April 15, 2010
    Applicant: SANTHERA PHARMACEUTICALS (SCHWEIZ) AG
    Inventors: Günther Metz, Holger Deppe, Ulrich Abel, Achim Feurer, Inge Ott, Sonja Nordhoff, Michael Soeberdt, Barbara Hoffmann-Enger, Philipp Weyermann, Hervé Siendt, Christian Rummey, Miroslav Terinek, Marco Henneböhle, Holger Herzner, Cesare Mondadori
  • Dpp-Iv Inhibitors
    Publication number: 20080275086
    Abstract: The invention relates to compounds of formula (I) wherein Z, R1-7, X and n have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.
    Type: Application
    Filed: February 20, 2006
    Publication date: November 6, 2008
    Inventors: Paul John Edwards, Silvia Cerezo-Galvez, Meritxell Lopez-Canet, Victor Giulio Matassa, Claudia Rosenbaum, Christian Rummey, Sonja Nordhoff
  • Dpp-IV Inhibitors
    Publication number: 20080015146
    Abstract: The invention relates to compounds of formula (I) wherein Z, R1-9, n, A, X and Rb have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.
    Type: Application
    Filed: June 8, 2005
    Publication date: January 17, 2008
    Applicant: SANTHERA PHARMACEUTICALS (DEUTSCHLAND) AG
    Inventors: Paul Edwards, Silvia Cerezo-Galvez, Achim Feurer, Victor Matassa, Sonja Nordhoff, Stephan Bulat, Meritxell Lopez-Canet, Christian Rummey, Claudia Rosenbaum
  • Dpp-IV Inhibitors
    Publication number: 20070265301
    Abstract: The invention relates to compounds of formula (I), wherein Z, R1-8, n, A1, X1 and X2 have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.
    Type: Application
    Filed: May 20, 2005
    Publication date: November 15, 2007
    Inventors: Paul Edwards, Victor Matassa, Achim Feurer, Sonja Nordhoff, Silvia Cerezo-Galvez, Christian Rummey
  • Dpp-IV Inhibitors
    Publication number: 20070265261
    Abstract: The invention relates to compounds of formula (1) wherein Z, R1-3 and A have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.
    Type: Application
    Filed: June 8, 2005
    Publication date: November 15, 2007
    Inventors: Paul Edwards, Claudia Rosenbaum, Christian Rummey, Silvia Cerezo-Galvez, Achim Feurer, Oliver Hill, Meinolf Thiemann, Victor Matassa, Sonja Nordhoff, Barbara Hoffmann